Radiolabeled Cationic Peptides for Targeted Imaging of Infection

Figure 3

Biodistribution of (a) ⁶⁴Cu-HLys-DOTA and (b) ⁶⁴Cu-AB1-HLys-DOTA in intramuscularly infected mice model at 1, 4, and 24 h post injection. (c) Comparison of dose uptake of ⁶⁴Cu-HLys-DOTA and ⁶⁴Cu-AB1-HLys-DOTA in the infected and PBS-injected control muscle. n = 4 for each time point, , , and show significant statistical analysis at .

(a)

(b)

(c)